MX2012008961A - Fluorometanos multiples sustituidos como isosteros selectivos y bioactivos. - Google Patents

Fluorometanos multiples sustituidos como isosteros selectivos y bioactivos.

Info

Publication number
MX2012008961A
MX2012008961A MX2012008961A MX2012008961A MX2012008961A MX 2012008961 A MX2012008961 A MX 2012008961A MX 2012008961 A MX2012008961 A MX 2012008961A MX 2012008961 A MX2012008961 A MX 2012008961A MX 2012008961 A MX2012008961 A MX 2012008961A
Authority
MX
Mexico
Prior art keywords
fluoromethanes
isosteres
bioactive
selective
multiple substituted
Prior art date
Application number
MX2012008961A
Other languages
English (en)
Inventor
Mark E Hediger
Original Assignee
Meh Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meh Associates Inc filed Critical Meh Associates Inc
Publication of MX2012008961A publication Critical patent/MX2012008961A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/27—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/54—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se divulgan fluorometanos sustituidos; composiciones farmacéuticas que comprenden una cantidad terapéuticamente efectiva de los mismos; procesos para preparar dichos fluorometanos; y métodos para el uso de los mismos en el alivio de infección y parasitismo. También se divulgan métodos para la identificación de fluorometanos sustituidos para modular la actividad de receptores y enzimas que enlazan y/o modifican ligandos y sustratos que contienen fosfato.
MX2012008961A 2010-02-03 2011-02-03 Fluorometanos multiples sustituidos como isosteros selectivos y bioactivos. MX2012008961A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30104210P 2010-02-03 2010-02-03
PCT/US2011/023657 WO2011097421A1 (en) 2010-02-03 2011-02-03 Multiple substituted fluoromethanes as selective and bioactive isosteres

Publications (1)

Publication Number Publication Date
MX2012008961A true MX2012008961A (es) 2013-04-29

Family

ID=44355784

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008961A MX2012008961A (es) 2010-02-03 2011-02-03 Fluorometanos multiples sustituidos como isosteros selectivos y bioactivos.

Country Status (11)

Country Link
US (1) US9199914B2 (es)
EP (1) EP2531465A4 (es)
JP (1) JP2013518897A (es)
KR (1) KR20130028058A (es)
CN (1) CN102811989A (es)
AU (1) AU2011212925A1 (es)
CA (1) CA2826623A1 (es)
IL (1) IL221298A0 (es)
MX (1) MX2012008961A (es)
WO (1) WO2011097421A1 (es)
ZA (1) ZA201205917B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9199914B2 (en) 2010-02-03 2015-12-01 Meh Associates, Inc. Multiple substituted fluoromethanes as selective and bioactive isosteres
DK2386682T3 (da) * 2010-04-27 2014-06-23 Omya Int Ag Fremgangsmåde til fremstilling af strukturerede materialer under anvendelse af nano-fibrillære cellulosegeler
PL2386683T3 (pl) * 2010-04-27 2014-08-29 Omya Int Ag Sposób wytwarzania materiałów kompozytowych na bazie żelu
CN102702257B (zh) * 2012-05-15 2014-08-13 武汉理工大学 一种用于高温质子交换膜中的含氮多膦酸烷氧基硅烷的制备方法
CN116057048A (zh) 2020-07-07 2023-05-02 罗维拉威尔吉利大学 用于有机化合物的多氟烷基硫醇化的试剂及其生产方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1567221A1 (de) * 1965-06-01 1970-04-16 Berlin Chemie Veb Systemische Fungizide
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
US5008202A (en) * 1988-11-29 1991-04-16 Sequoia Turner Corporation Blood diluent for red blood cell analysis
DE4008179A1 (de) * 1990-03-12 1991-09-19 Schering Ag Fluorbenzolsulfonamide
JPH0948792A (ja) * 1994-12-28 1997-02-18 Sumitomo Pharmaceut Co Ltd ルイスｘ誘導体
IT1277737B1 (it) 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
US5917074A (en) 1997-10-07 1999-06-29 University Of Massachusetts Preparation and applications of fluorinated propargyl phosphonate reagents
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
ATE309207T1 (de) 1999-08-27 2005-11-15 Sugen Inc Phosphat-mimetika sowie behandlungsmethoden unter verwendung von phosphatase-inhibitoren
JP2003533546A (ja) * 2000-05-22 2003-11-11 スミスクライン・ビーチャム・コーポレイション Ｍｕｒａ活性をモジュレーションする方法
US20040033896A1 (en) 2000-06-02 2004-02-19 Gerard Koether Substituted pyrimidine and pyridine herbicides
CZ305971B6 (cs) * 2000-12-28 2016-06-01 Kissei Pharmaceutical Co., Ltd. Deriváty glukopyranosyloxypyrazolu a jejich použití v léčivech
AU2002305073A1 (en) * 2001-03-22 2002-10-08 Research Foundation Of The City University Of New York Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
US7420002B2 (en) * 2001-06-11 2008-09-02 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
SE0202430D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
US7670631B2 (en) * 2003-03-12 2010-03-02 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
JP4484027B2 (ja) * 2003-12-08 2010-06-16 三菱瓦斯化学株式会社 光学活性２―アルキル−ｄ−システインアミド又はその塩、及びこれらの化合物の製造方法。
KR20140033237A (ko) * 2005-10-07 2014-03-17 엑셀리시스, 인코포레이티드 포스파티딜이노시톨 3-키나아제 억제제 및 이의 사용 방법
JP5099692B2 (ja) 2005-12-27 2012-12-19 国立大学法人群馬大学 新規トリハロメチオニン誘導体及びそれを含む医薬
AU2007253819B2 (en) * 2006-05-23 2011-02-17 Irm Llc Compounds and compositions as channel activating protease inhibitors
US8242174B2 (en) 2007-02-01 2012-08-14 Panthera Biopharma Llc Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
CA2686994A1 (en) 2007-05-11 2008-11-20 Mpex Pharmaceuticals, Inc. Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
WO2009081958A1 (ja) * 2007-12-26 2009-07-02 Shionogi & Co., Ltd. グリコペプチド抗生物質配糖化誘導体
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
JP2011006359A (ja) * 2009-06-26 2011-01-13 Nagoya Institute Of Technology トリフルオロメチルメチオニン及びその誘導体の簡便合成方法。
US9199914B2 (en) 2010-02-03 2015-12-01 Meh Associates, Inc. Multiple substituted fluoromethanes as selective and bioactive isosteres

Also Published As

Publication number Publication date
WO2011097421A1 (en) 2011-08-11
CN102811989A (zh) 2012-12-05
CA2826623A1 (en) 2011-08-11
WO2011097421A8 (en) 2011-10-27
EP2531465A4 (en) 2015-12-30
AU2011212925A1 (en) 2012-09-06
EP2531465A1 (en) 2012-12-12
JP2013518897A (ja) 2013-05-23
US9199914B2 (en) 2015-12-01
KR20130028058A (ko) 2013-03-18
IL221298A0 (en) 2012-10-31
US20120302519A1 (en) 2012-11-29
ZA201205917B (en) 2013-10-30

Similar Documents

Publication Publication Date Title
MX2022010490A (es) Composiciones utiles para enzimas de internalizacion.
EA029089B9 (ru) Модуляторы метил-модифицирующих ферментов, композиции и их применение
JOP20110402B1 (ar) الأجسام المضادة ل cd38
AU2011328009A8 (en) Compounds and methods for treating pain
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
MX366130B (es) Inhibidores bivalentes de las proteinas iap y métodos terapéuticos que usan los mismos.
UA108912C2 (uk) БІЛОК, ЯКИЙ ЗВ'ЯЗУЄ TNF-α
UA104005C2 (ru) 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
MX342509B (es) Compuestos de indazol sustituidos como inhibidores de las cinasas de proteina.
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
GB201106750D0 (en) Novel compounds
MX2013003309A (es) Compuestos de benzamida sustituidos.
TN2012000415A1 (en) Pharmaceutical composition comprising a pyrimidineone derivative
WO2013023084A3 (en) Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells
WO2012064897A3 (en) Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
MX2012008961A (es) Fluorometanos multiples sustituidos como isosteros selectivos y bioactivos.
UA111599C2 (uk) Композиція каспофунгіну
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
UA113409C2 (xx) Солі азабіциклічних діарилових ефірів та способи їх одержання або одержання їх попередників
CA2843847C (en) Use of (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
IN2015DN03734A (es)
MY148732A (en) Triazolium salts as par1 inhibitors, production thereof, and use as medicaments